Structure | Chemical Name | CAS | MF |
|
1H-Benzimidazol-2-amine,N,5,6-trimethyl-(9CI)
|
107903-00-4
|
C10H13N3
|
|
Isomurrayafoline B
|
107903-15-1
|
C19H21NO2
|
|
ETHYL MORPHOLINE-2-CARBOXYLATE
|
107904-06-3
|
C7H13NO3
|
|
Ethyl 4-Benzyl-2-morpholinecarboxylate
|
107904-08-5
|
C14H19NO3
|
|
ETHYL 2-[BIS(2,2,2-TRIFLUOROETHYL)PHOSPHONO] PROPIONATE
|
107905-52-2
|
C9H13F6O5P
|
|
methyl (4S)-4-[[(2S)-2-[[2-[[(3R,4S,5S,6R)-3-acetamido-2,5-dihydroxy-6 -(hydroxymethyl)oxan-4-yl]amino]acetyl]amino]propanoyl]amino]-4-carbam oyl-butanoate
|
107910-43-0
|
C19H33N5O10
|
|
N-(2-acetamido-2,3-dideoxyglucos-3-yl)glycyl-alanyl-glutamine methyl ester
|
107910-44-1
|
C19H33N5O10
|
|
Ganciclovir sodium
|
107910-75-8
|
C9H14N5NaO4
|
|
beta-methylmelibiose
|
107911-44-4
|
C13H24O11
|
|
Cyclopropanecarboxamide, 2-(1,1-dimethylethyl)-, (1R-trans)- (9CI)
|
107912-94-7
|
C8H15NO
|
|
3-O-Feruloylsucrose
|
107912-97-0
|
C22H30O14
|
|
2-amino-5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-epoxynaphthalene
|
107914-05-6
|
C12H15NO3
|
|
2-guanidino-5,8-dimethoxy-1,2,3,4-tetrahydro-1,4-epoxynaphthalene
|
107914-11-4
|
C13H17N3O3
|
|
Flavone, 6-amino-3-hydroxy- (6CI)
|
107915-41-3
|
C15H11NO3
|
|
4H-1-Benzopyran-4-one,7-amino-3-hydroxy-2-phenyl-(9CI)
|
107915-42-4
|
C15H11NO3
|
|
1-(4-hexoxyphenyl)ethanamine
|
107916-76-7
|
C14H23NO
|
|
AKOS B018336
|
107916-92-7
|
C14H9NOS2
|
|
3'-CYANO-BIPHENYL-2-CARBOXYLIC ACID
|
107916-96-1
|
C14H9NO2
|
|
2-Phenanthridinecarboxylic acid, 5,6-dihydro-6-oxo-
|
107917-50-0
|
C14H9NO3
|
|
4H-1-Benzopyran-4-one,6-amino-2-(3-hydroxyphenyl)-(9CI)
|
107917-99-7
|
C15H11NO3
|
|
4-ISOTHIOCYANATO-N-(2-METHYLPHENYL)BENZENESULFONAMIDE
|
107920-20-7
|
C14H12N2O2S2
|
|
Methyl 4-(phenylsulfonaMido)benzoate
|
107920-79-6
|
C14H13NO4S
|
|
(4-CHLORO-BENZYL)-(3-MORPHOLIN-4-YL-PROPYL)-AMINE
|
107921-37-9
|
C14H21ClN2O
|
|
Methyl 3-benzenesulfonaMidobenzoate
|
107922-46-3
|
C14H13NO4S
|
|
(2-CHLORO-BENZYL)-(3-MORPHOLIN-4-YL-PROPYL)-AMINE
|
107922-87-2
|
C14H21ClN2O
|
|
4-(2-CYANOACETYL)METHANE SULFONANILIDE
|
107929-91-9
|
C10H10N2O3S
|
|
4,6-diamino-5-guanidinopyrimidine
|
107930-05-2
|
C5H9N7
|
|
2-(2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraen-8-yl)acetonitrile
|
107932-97-8
|
C8H6N4
|
|
corrigendum
|
107933-32-4
|
C32H34N2O5S2
|
|
5-(IODOMETHYL)-1H-TETRAZOLE
|
107933-72-2
|
C2H3IN4
|
|
IMidazo[1,2-a]pyridin-2(3H)-one hydrobroMide
|
107934-07-6
|
C7H7BrN2O
|
|
Hexanedioic acid, polymer with 1,4-butanediol, 1,6-diisocyanatohexane and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
|
107934-19-0
|
C30H50N4O10
|
|
9,9-BIS(4-AMINO-3-METHYLPHENYL)FLUORENE
|
107934-60-1
|
C27H24N2
|
|
4,4'-(9H-Fluoren-9-ylidene)bis(2-chlorobenzenamine)
|
107934-68-9
|
C25H18Cl2N2
|
|
Hemolysin,kanagawa
|
107935-42-2
|
|
|
cystatin alpha
|
107935-53-5
|
|
|
alpha-gliadin (43-49)
|
107936-65-2
|
C43H57N9O11
|
|
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-aMino-8-oxo-3-(1E)-1-propenyl-, (6R,7R)-
|
107937-01-9
|
C10H12N2O3S
|
|
1-Propyl-2,3-diMethyliMidazoliuM broMide
|
107937-17-7
|
C8H15BrN2
|
|
Piperazine, 1-(1,1-dimethylethyl)-4-nitroso- (9CI)
|
107938-04-5
|
C8H17N3O
|
|
6H-1,3-Thiazin-6-one,2-ethoxy-5-methoxy-4-methyl-(9CI)
|
107938-82-9
|
C8H11NO3S
|
|
2-Quinoxalinecarbonitrile,3-amino-4,6,7,8-tetrahydro-4-methyl-(9CI)
|
107938-84-1
|
C10H12N4
|
|
2-(4-CHLOROANILINO)-1H-ISOINDOLE-1,3(2H)-DIONE
|
107940-74-9
|
C14H9ClN2O2
|
|
2-bromo-1,4,5-trimethoxynaphthalene
|
107941-22-0
|
C13H13BrO3
|
|
Ethanone, 1-[3,4-dihydro-5-(1-methylethyl)-2H-pyrrol-3-yl]- (9CI)
|
107942-24-5
|
C9H15NO
|
|
Ethanone, 1-(5-ethyl-3,4-dihydro-2H-pyrrol-3-yl)- (9CI)
|
107942-25-6
|
C8H13NO
|
|
Ethanone, 1-[3,4-dihydro-5-(methylthio)-2H-pyrrol-3-yl]- (9CI)
|
107942-26-7
|
C7H11NOS
|
|
1,6-Diazabicyclo[3.1.0]hexane-5-carboxylicacid,6-methoxy-,methylester,(1-alpha-,5-alpha-,6-alpha-)-(9CI)
|
107946-22-5
|
C7H12N2O3
|
|
(1S,2S)-5-methoxy-3,3-dimethyl-2-(1-piperidylmethyl)-1,2-dihydroinden- 1-ol hydrochloride
|
107946-34-9
|
C18H28ClNO2
|
|
4-CHLORO-3-PYRROLIDIN-1-YL-BENZOIC ACID
|
107946-68-9
|
C11H12ClNO2
|
|
4-chloro-3-(1H-pyrrol-1-yl)benzoic acid
|
107946-72-5
|
C11H8ClNO2
|
|
4-METHYL-3-PYRROLIDIN-1-YL-BENZOIC ACID
|
107946-74-7
|
C12H15NO2
|
|
5-(pyrrolidin-1-yl)nicotinic acid
|
107946-76-9
|
C10H12N2O2
|
|
2-BENZYLAMINO-5-NITRO-BENZOIC ACID
|
107946-93-0
|
C14H12N2O4
|
|
4-(methyl-phenyl-amino)thiophene-3-carboxylic acid
|
107947-00-2
|
C12H11NO2S
|
|
methyl 3-bromo-4-chlorobenzoate
|
107947-17-1
|
C8H6BrClO2
|
|
2-octulosonic acid
|
107947-93-3
|
C8H14O9
|
|
1-[(4-Ethylphenyl)ethynyl]-4-(trans-4-propylcyclohexyl)benzene
|
107949-21-3
|
C25H30
|
|
preproatrial natriuretic factor (56-92)
|
107949-88-2
|
|
|
neuropeptide Y, Nle(4)-
|
107949-91-7
|
|
|
pancreatic polypeptide, salmon
|
107949-92-8
|
|
|
ACTH, formylmethionyl-
|
107949-95-1
|
C5H12
|
|
DENDROTOXIN I
|
107950-33-4
|
|
|
lactacin F
|
107950-55-0
|
|
|
2-[2-(4-methoxyphenoxy)acetyl]-N-phenyl-1-hydrazinecarbothioamide
|
107951-85-9
|
C16H17N3O3S
|
|
5-[(4-METHOXYPHENOXY)METHYL]-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL
|
107951-97-3
|
C16H15N3O2S
|
|
2,4-Dihydro-4-(3-chlorophenyl)-5-((2-methoxyphenoxy)methyl)-3H-1,2,4-t riazole-3-thione
|
107952-07-8
|
C16H14ClN3O2S
|
|
2,4-Dihydro-4-(4-ethoxyphenyl)-5-((2-methoxyphenoxy)methyl)-3H-1,2,4-t riazole-3-thione
|
107952-08-9
|
C18H19N3O3S
|
|
Methyl 3,4-Di-O-acetyl--L-idopyranosiduronate, 1,2-(Methylorthoacetate)
|
107952-66-9
|
C14H20O10
|
|
(11β)-11,21-Bis(acetyloxy)pregna-4,16-diene-3,20-dione
|
107952-99-8
|
C25H32O6
|
|
1,4-Dimethoxy-2-hydroxyanthraquinone
|
107953-78-6
|
C16H12O5
|
|
1,4-Oxathiin, 5,6-dihydro-3-(hydroxymethyl)-2-methyl-
|
107954-67-6
|
C6H10O2S
|
|
6-BROMO-2,5-DIOXO-1,2,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBONITRILE
|
107955-83-9
|
C10H7BrN2O2
|
|
Thiazolo[4,5-f]quinolin-7(6H)-one, 8-amino- (9CI)
|
107955-85-1
|
C10H7N3OS
|
|
Phosphorodithioic acid, S-((4,6-diamino-1,3,5-triazin-2-yl)methyl) O,O -dimethyl ester, mixt. with (1alpha,2alpha,3beta,4alpha,5alpha,6beta)- 1,2,3,4,5,6-hexachlorocyclohexane
|
107959-15-9
|
C12H18Cl6N5O2PS2
|
|
N-(1,2,2,2-TETRACHLOROETHOXYCARBONYLOXY)SUCCINIMIDE
|
107960-02-1
|
C7H5Cl4NO5
|
|
1H-Pyrrole-1-carboxamide,N-2-propenyl-(9CI)
|
107962-30-1
|
C8H10N2O
|
|
Spiro[cyclopropane-1,5(4H)-[4,7]methano[1,2]benzisoxazole] (9CI)
|
107962-84-5
|
C10H9NO
|
|
Spiro[cyclopropane-1,6(2H)-[4,7]methano[1,2]benzisoxazole] (9CI)
|
107962-85-6
|
C10H9NO
|
|
N-(3,4-DIMETHOXYPHENYL)THIOACETAMIDE
|
107963-01-9
|
C10H13NO2S
|
|
(2-METHOXY-PHENOXY)-ACETIC ACID HYDRAZIDE
|
107967-88-4
|
C9H12N2O3
|
|
3-Oxatricyclo[3.2.1.02,4]octane,6-nitro-,(1-alpha-,2-bta-,4-bta-,5-alpha-,6-bta-)-(9CI)
|
107969-31-3
|
C7H9NO3
|
|
Tricyclo[2.2.1.02,6]heptan-3-ol, 1-nitro-, stereoisomer (9CI)
|
107969-32-4
|
C7H9NO3
|
|
Methyl (E)-2-oxo-4-phenyl-3-butenoate
|
107969-78-8
|
C11H10O3
|
|
1-Methyl-5-phenyl-1,2-dihydro-2-oxopyridine
|
107971-01-7
|
C12H11NO
|
|
2(1H)-Pyridinimine,1,3-dimethyl-(9CI)
|
107971-05-1
|
C7H10N2
|
|
5-CarbaMoyl-1-Methyl-2-picoliniuM Iodide
|
107971-06-2
|
C8H11IN2O
|
|
PHENYL 3,4-DIHYDRO-2-METHYL-4-OXOPYRIDINE-1(2H)-CARBOXYLATE
|
107971-38-0
|
C13H13NO3
|
|
2-Furancarboxamide,N-(2-hydroxyethyl)-(9CI)
|
107973-15-9
|
C7H9NO3
|
|
5-Thiazolethiol,2-amino-4-methyl-(9CI)
|
107974-24-3
|
C4H6N2S2
|
|
2-t-butoxypyrimidine
|
107976-32-9
|
C8H12N2O
|
|
Isoxazole, 3-methyl-5-(3-methylbutyl)- (9CI)
|
107978-58-5
|
C9H15NO
|
|
FIBRONECTIN TYPE III CONNECTING SEGMENT FRAGMENT 1-25
|
107978-77-8
|
C123H195N31O39
|
|
CS4 peptide
|
107978-80-3
|
C139H219N45O39
|
|
FIBRONECTIN TYPE III CONNECTING SEGMENT FRAGMENT 90-109
|
107978-81-4
|
C107H158N28O34
|
|
1-(2,2-Diethoxyethyl)-3-allylurea
|
107979-42-0
|
C10H20N2O3
|
|
2-Butenedioic acid (Z)-, polymer with 2-propenenitrile and 2-propenoic acid, ammonium salt
|
107979-57-7
|
C10H11NO6
|
|
1,3-Dioxolane-4-carboxylicacid,2,2,5-trimethyl-,(4R-trans)-(9CI)
|
107983-40-4
|
C7H12O4
|
|
(1S,3S)-3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID
|
107983-78-8
|
C6H10O3
|
|
2-Acetamido-4-bromophenol
|
107986-49-2
|
C8H8BrNO2
|